http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2763477-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe216aafd92230af08bea3ad94a69638
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 2021-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_934580d713dcfc8df44ebcae9fce287a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df515287fe384059639aa7113e17842e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9b07b7de18e9c3d5964c892f59770d7
publicationDate 2021-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2763477-C1
titleOfInvention Method for the surgical treatment of large and recurrent macular ruptures
abstract FIELD: medicine.SUBSTANCE: invention relates to the field of medicine, namely to ophthalmology. A 3-port vitrectomy 25-27G is performed with isolation and removal of the posterior hyaloid membrane, staining and removal of the internal boundary membrane (IPM). In the vitreous cavity, balanced salt solution (BSS) is replaced with air. Then a drop of blood plasma is applied to the area of the rupture, and after the formation of a fibrin film on it, a drop of PFOS is placed on it, and kept in time. Then, by passive aspiration, PFOS is removed, and finally, the air is replaced with saline, while 1/2-3/4 of the air volume is left in the vitreous cavity. In this case, a drop of PFOS is tamped on a drop of blood plasma for 8 minutes. After completing the operation, the patient is placed face down for 12 hours.EFFECT: method allows performing atraumatic surgical treatment of large sizes (more than 500 microns) and recurrent macular ruptures.1 cl, 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2799740-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2786140-C1
priorityDate 2021-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2698633-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2688395-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966231
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534973
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407191297

Total number of triples: 33.